Bausch & Lomb (BLCO) Share-based Compensation (2021 - 2026)
Bausch & Lomb (BLCO) posted Share-based Compensation of $34.0 million for Q1 2026, up 148.57% on a QoQ basis from -$70.0 million in Q4 2025, and up 21.43% year-over-year from $28.0 million in Q1 2025.
Bausch & Lomb (BLCO) Share-based Compensation (2021 - 2026) Analysis & Trends
Bausch & Lomb's Share-based Compensation history runs 6 years deep, the most recent figure standing at $34.0 million for Q1 2026.
- Quarterly Share-based Compensation rose 21.43% year-over-year to $34.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.0 million (down 79.21% YoY) and the FY2025 annual result came in at $15.0 million, down 83.7% from the prior year.
- Share-based Compensation was $34.0 million for Q1 2026 at Bausch & Lomb, up from -$70.0 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $83.0 million in Q4 2024 and bottomed at -$70.0 million in Q4 2025.
- A 5-year average of $16.3 million and a median of $19.0 million in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation tumbled 263.64% — and 2024, when it soared 418.75%.
- Bausch & Lomb's Share-based Compensation stood at $17.0 million in 2022, then declined by 5.88% to $16.0 million in 2023, then surged by 418.75% to $83.0 million in 2024, then tumbled by 184.34% to -$70.0 million in 2025, then soared by 148.57% to $34.0 million in 2026.
- Business Quant data shows BLCO's Share-based Compensation at $34.0 million in Q1 2026, -$70.0 million in Q4 2025, and $27.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 45.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 13.10 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 58.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 26.79 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 51.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 40.92 Mn |
| 10 | Bausch & Lomb | 5.68 Bn | 5.47 Bn | 973.00 Mn | 34.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.00 Mn |
| Mar 31, 2026 | 34.00 Mn |
| Dec 31, 2025 | -70.00 Mn |
| Dec 31, 2025 | -70.00 Mn |
| Sep 30, 2025 | 27.00 Mn |
| Sep 30, 2025 | 27.00 Mn |
| Jun 30, 2025 | 30.00 Mn |
| Jun 30, 2025 | 30.00 Mn |
| Mar 31, 2025 | 28.00 Mn |
| Mar 31, 2025 | 28.00 Mn |
| Dec 31, 2024 | 83.00 Mn |
| Dec 31, 2024 | 83.00 Mn |
| Sep 30, 2024 | -32.00 Mn |
| Sep 30, 2024 | -32.00 Mn |
| Jun 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 22.00 Mn |
| Mar 31, 2024 | 19.00 Mn |
| Mar 31, 2024 | 19.00 Mn |
| Dec 31, 2023 | 16.00 Mn |
| Dec 31, 2023 | 16.00 Mn |